Adalank vs Selank compared: research evidence, chemical structure, typical routes, and regulatory status, plus what US researchers should verify before buying.
Adalank and Selank are both synthetic research peptides studied for their effects on mood, anxiety, and cognition, but they are not the same compound. Selank is a tuftsin-derived heptapeptide with decades of published research behind it, while Adalank is a lesser-documented peptide marketed as a Selank analog with very little peer-reviewed evidence. Neither peptide is FDA-approved for human use in the United States, and both are sold strictly as laboratory research chemicals.
What Is Selank?
Selank is a synthetic heptapeptide derived from tuftsin, an immunomodulatory peptide fragment. Researchers developed it in Russia in the 1990s, and it has since been the subject of preclinical and clinical studies focused on anxiety, attention, and stress regulation.
- Class: synthetic heptapeptide (tuftsin analog), frequently supplied as Selank amidate
- Main research focus: anxiolytic and nootropic activity, GABA and monoamine signaling
- Routes used in studies: intranasal and subcutaneous
- US regulatory status: not FDA-approved; sold as a research chemical
Selank has an established research footprint, which is why it appears so often in peptide literature discussions — including comparisons like selank vs n-acetyl selank, where investigators look at how a small chemical modification changes stability and half-life.
What Is Adalank?
Adalank is a much newer entry in the research peptide market, typically described by suppliers as a modified Selank analog built for greater stability. The difficulty is that nearly all available information about Adalank comes from vendor marketing rather than independent, peer-reviewed studies.
That does not automatically mean Adalank is worthless as a research subject — it means the evidence base is thin. Investigators evaluating it should expect to find very few primary sources and should treat potency claims from sellers with caution.
How Adalank is usually sold
- Listed as a Selank analog or "next-generation Selank"
- Commonly shipped as a lyophilized powder for reconstitution
- Independent third-party testing is often missing or impossible to verify
- Published sequence data may be withheld or described only in general terms
Adalank vs Selank: Side-by-Side Comparison
| Feature | Selank | Adalank |
|---|---|---|
| Chemical class | Synthetic heptapeptide (tuftsin analog) | Marketed as a modified Selank analog; structure not always disclosed |
| Published research | Multiple animal and human studies, largely Russian | Very limited; mostly vendor-supplied material |
| Primary research interest | Anxiety, cognition, stress response | Claimed anxiolytic and cognitive effects |
| Typical research route | Intranasal, subcutaneous | Intranasal, subcutaneous (per vendor guidance) |
| US regulatory status | Not FDA-approved | Not FDA-approved |
| Purity documentation | Certificates of analysis commonly available | Inconsistent across suppliers |
The most important column in that table is the second one. Selank has a documented research history that can be read, cited, and critiqued. Adalank largely does not, so any comparison between the two depends heavily on how much weight a reader gives to supplier claims.
Where the Two Peptides Overlap
In practice, Adalank and Selank occupy the same research niche: peptides investigated for anxiolytic and cognitive effects, usually delivered intranasally. Both are handled as laboratory materials, not as approved drugs.
Handling and storage requirements are nearly identical for the two compounds. Anyone reconstituting either peptide needs to understand the difference between bac water vs sodium chloride, because the choice of diluent affects pH, peptide stability, and how long a prepared solution remains usable.
What to Verify Before Buying Either Peptide
- Batch-matched third-party purity testing, ideally HPLC and mass spectrometry
- Disclosure of the exact peptide sequence and any structural modifications
- Cold-chain shipping and clear storage instructions
- Labeling that states "not for human consumption"
- Citable primary literature — not blog posts or product pages
Delivery method is another variable worth attention. Research on other compounds has shown that the route of administration can change absorption and onset substantially, which is why questions such as pt-141 nasal spray vs injection matter across the wider peptide literature.
It also helps to keep the broader landscape in view. Investigators frequently screen several compounds at once, and debates like aod 9604 vs mots-c for a metabolic study come up alongside central nervous system peptides. The same standards of evidence apply to all of them.
Safety, Legality, and Realistic Expectations
Neither Adalank nor Selank is approved by the FDA for human use, and neither has a recognized human dose. Personal use sits in a legal gray area in the United States, and quality control in the gray market is unreliable at best.
Anyone exploring these peptides for a medical reason — anxiety, focus, or sleep — should speak with a licensed healthcare professional instead. Approved treatments exist for those conditions, and self-experimentation with unverified peptides carries genuine risks, including contamination and unpredictable immune reactions.
Selank has substantially more published research behind it than Adalank, and that gap in evidence is the single biggest difference between the two peptides.
Bottom Line
Adalank vs Selank is not a close contest when it comes to documentation. Selank is a characterized tuftsin analog with a real, if limited, research history; Adalank is a marketed analog with almost no independent data.
For a study that needs a citable evidence base, Selank is the more defensible starting point. If Adalank is of interest, treat every claim about it as unverified until a primary source proves otherwise.
Frequently Asked Questions
Is Adalank the same as Selank?
No. Adalank is marketed as a modified Selank analog, but the two are distinct products, and the exact structure of Adalank is not always disclosed by sellers. Selank is a defined tuftsin-derived heptapeptide with published research behind it, while Adalank has very little independent data. Neither is FDA-approved for human use.
Is Selank FDA-approved for human use?
No. Selank is not approved by the FDA for any human indication in the United States and is sold as a research chemical. Human dosing information is not established, and products sold online are not guaranteed to match their labels. Anyone with a medical concern should consult a licensed healthcare professional rather than self-experimenting.
Which has more research behind it, Adalank or Selank?
Selank has substantially more research behind it, including animal and human studies conducted mainly in Russia. Adalank is a newer market entry with almost no peer-reviewed literature, so most available information comes from vendor marketing. That difference in evidence is the main practical distinction between the two peptides.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.